Investing

Natera : NTRA

NTRA

Stock Data

$207.28

$1.12 (0.54%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Natera Inc is a pioneering diagnostics company that offers a wide range of molecular testing services globally. Its innovative portfolio includes Panorama, a non-invasive prenatal test for chromosomal abnormalities, and Horizon, a carrier screening test. Natera also provides Vistara, Spectrum, Anora, Empower, and a non-invasive prenatal paternity product. Additionally, it offers Signatera for cancer recurrence monitoring, Altera for genomic profiling, Prospera for transplant rejection assessment, and Renasight for kidney gene panel testing. Natera enhances its offerings through partnerships and a cloud-based software, Constellation, facilitating access to its advanced algorithms and bioinformatics. Founded in 2003, Natera is headquartered in Austin, Texas.

All Natera Articles

10 Articles

Thomas Richmond | Apr 13, 2026 at 2:36 PM EDT

Stanley Druckenmiller Made 1 Huge Bet That Still Looks Attractive Today and Cut 2 Top Positions

Billionaire investor Stanley Druckenmiller is known for making bold moves when conviction is high, and his latest portfolio changes suggest…

Omor Ibne Ehsan | Apr 1, 2026 at 1:34 PM EDT

Stanley Druckenmiller Loaded Up on This Stock That’s Down 77%

Stanley Druckenmiller is a legendary Wall Street investor, and there are very few investors on Wall Street with such an…

Joel South | Mar 11, 2026 at 10:26 AM EDT

Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More

Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent…

Lee Jackson | Jan 7, 2026 at 8:04 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Applied Digital, BigBear.ai, Block, Deckers Outdoors, GitLab, Hershey, McDonald’s, Moderna, and More

Pre-Market Stock Futures: The futures are trading flat on Wednesday after a second strong day for Wall Street, as the…

Omor Ibne Ehsan | Dec 11, 2025 at 9:11 AM EST

Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks

Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been…

John Seetoo | Dec 1, 2025 at 8:01 PM EST

Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock

Prognostications that the AI bubble is grossly overbought have been increasing. The fact that the Magnificent 7 AI stocks, such…

Omor Ibne Ehsan | Nov 24, 2025 at 11:38 AM EST

This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.

Stanley Druckenmiller has been one of the most successful investors, a billionaire with a long record of high returns in…

Joey Frenette | Jul 25, 2025 at 11:53 AM EDT

TWST vs. NTRA: Which Genomics Play Is a Better Buy?

Cathie Wood’s Ark funds have been really heating up in recent months. Perhaps her most intriguing and underrated fund is…

Joey Frenette | Feb 4, 2025 at 10:58 AM EST

Billionaire Stanley Druckenmiller says the AI boom could get much bigger – These are the stocks he owns

Stanley Druckenmiller is one of those legendary investors who are worth listening to and learning from. The man, who’s worth…

Lee Jackson | Dec 29, 2023 at 8:45 AM EST

Ride-Sharing Stocks Highlight Friday’s Top Wall Street Upgrades and Downgrades

The last trading day of 2023 got off to a flat start, and the two premier ride-sharing stocks both received…